Ribocure Pharmaceuticals AB Revenue and Competitors
Estimated Revenue & Valuation
- Ribocure Pharmaceuticals AB's estimated annual revenue is currently $6M per year.
- Ribocure Pharmaceuticals AB's estimated revenue per employee is $155,000
Employee Data
- Ribocure Pharmaceuticals AB has 39 Employees.
- Ribocure Pharmaceuticals AB grew their employee count by 160% last year.
Ribocure Pharmaceuticals AB's People
Name | Title | Email/Phone |
---|---|---|
1 | VP & Head Global Clinical Development | Reveal Email/Phone |
2 | Head Data Science and IT | Reveal Email/Phone |
3 | Head Clinical Operations | Reveal Email/Phone |
4 | Associate Director Clinical Operations | Reveal Email/Phone |
5 | Executive Director, Global Head DMPK and Clinical Pharmacology | Reveal Email/Phone |
6 | Associate Director Clinical Operations | Reveal Email/Phone |
7 | Regulatory Affairs Director | Reveal Email/Phone |
8 | Avtalsspecialist | Reveal Email/Phone |
9 | Business Planning Lead | Reveal Email/Phone |
10 | Associate Principal Scientist | Reveal Email/Phone |
Ribocure Pharmaceuticals AB Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $140.3M | 905 | 14% | N/A | N/A |
#2 | $18.9M | 122 | -15% | N/A | N/A |
#3 | $23.4M | 151 | 5% | N/A | N/A |
#4 | $27.7M | 179 | -14% | N/A | N/A |
#5 | $8.8M | 57 | -12% | N/A | N/A |
#6 | $5.3M | 34 | -35% | N/A | N/A |
#7 | $26M | 168 | 20% | N/A | N/A |
#8 | $17.5M | 113 | -23% | N/A | N/A |
#9 | $12.7M | 82 | 14% | N/A | N/A |
#10 | $30.7M | 198 | 16% | N/A | N/A |
What Is Ribocure Pharmaceuticals AB?
A Swedish company focusing on research and development of oligonucleotide therapeutics.
keywords:N/AN/A
Total Funding
39
Number of Employees
$6M
Revenue (est)
160%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.4M | 39 | 8% | N/A |
#2 | $4.6M | 40 | -33% | N/A |
#3 | $4.6M | 40 | 33% | N/A |
#4 | $5.4M | 40 | -22% | N/A |
#5 | $3.5M | 40 | 0% | N/A |